• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Cytovance Biologics

    Syngene

    PCI Pharma Services

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Flow Sciences

    Syngene

    PCI Pharma Services

    Emergent BioSolutions

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Sterile Manufacturing Technology Trends

    Eliminating the risk of contamination in biologics manufacturing with SBV technology.

    Sterile Manufacturing Technology Trends
    Sterile Manufacturing Technology Trends
    1a: Dock SIP Cap illustration
    Sterile Manufacturing Technology Trends
    1b: SIP through Cap – Pre-Sterilizing Active & Vessel illustration
    Sterile Manufacturing Technology Trends
    Illustration 2a
    Sterile Manufacturing Technology Trends
    Illustration 2b
    Sterile Manufacturing Technology Trends
    Table 1
    Related CONTENT
    • Biologics Development & Manufacturing
    • Chemical Development
    • Precision Medicine Group Acquires Project Farma
    • Charles River Partners with JADE
    • Cytiva Delivers Modular Biologics Factory to Lonza
    Christian Dunne, ChargePoint Technology09.09.20
    The global contract manufacturing organization (CMO) market is growing at a compound annual growth (CAGR) of 12–13 percent between 2018 and 2022. The growth is attributed to increased outsourcing of generic drugs by Big Pharma companies. Additionally, medium and small pharma and biopharma companies, who do not possess adequate infrastructure, will also outsource, thereby driving the market. Presently, non-sterile drug manufacturing dominates the global CMO market. However, the sterile manufacturing market is expected to grow at a higher rate (15 percent) than the non-sterile market (9 percent) thru 2022.

    Manufacturing environments
    As sterile drug products are on the rise, manufacturing environments are challenged to ensure that suitable control measures are put in place to mitigate many sources of potential contamination.  These include operators, equipment and other materials present in the manufacturing environment. Should microorganisms, particles or endotoxins enter the manufacturing environment, patient safety could be put at risk.

    Several technologies have been developed over the years to ensure the sterile transfer of products and their drug substance during aseptic processing. Examples include restricted access barrier systems (RABS) and isolators. RABS provide a barrier between processing lines and operators, but also allow operators to interact with products where necessary. Isolators provide an airtight barrier around the processing line and when used in cleanroom environments can minimize the risk from contaminants. 

    Both RABS and isolator technologies have disadvantages, however. Materials transfer can be a difficult process when using an isolator, which can delay the shut down and start up process between batches, and RABS technology relies on manual cleaning processes, which can create delays between uses if not carefully managed.

    The advantages of Split Butterfly Valve technology
    The aseptic Spilt Butterfly Valve (SBV) provides a safe method of transferring drug substance or product from one container, process vessel, isolator or RABS to another while ensuring the sterility of the transfer is not compromised.

    Fundamentally the SBV consists of two halves, the active (Alpha) unit and the passive (Beta) unit. Each half consists of half of the ‘butterfly’ disc. The active unit is attached to the stationary process equipment such as a mixing vessel, while the passive unit is attached to the mobile container such as an intermediate bulk container (IBC) or flexible bag. When the two parts are brought together, the disc halves join to form a single disc, sealing any surfaces which may have been exposed to a compound during transfer. The two discs then operate as one disc and can be opened to allow transfer of product from one location to another. 

    The unique design of the aseptic SBV enables decontamination to take place in a closed environment. Once sealed, a gap is created between the discs and hydrogen peroxide gas is flushed through this enclosure to decontaminate the space. Chemical indicators (Cis) are used to validate and confirm full coverage of the enclosure has been achieved, followed by the use of biological indicators (BIs) to ensure a 99.9999% reduction, known as a 6-log reduction, in bacterial spores has been successful.

    Adoption of aseptic SBV technology allows manufacturers to benefit from a closed handling method that not only achieves the required sterility assurance level (SAL) and reduces the requirement for manual intervention, but also offers the opportunity to reduce the resource associated with cleaning and validating large areas. The method minimizes cleaning requirements and, consequently, downtime, while also increasing flow and yield from product transfers.

    Processing time varies between four and 30 minutes depending on the gassing system utilized. This is extremely fast when compared to a conventional airlock or isolator which could be in the region of 4–6 hours. SBVs can also contribute considerable cost savings in comparison to traditional approaches, being as much as three to five times cheaper than alternative methods. The aseptic SBV also makes it possible to downgrade the surrounding cleanroom environment because of the integrity of the approach.

    Case study
    A North American CDMO required a solution to ensure the sterile transfer of API’s at its facility.
    The CDMO is a full-service pharmaceutical company that specializes in the supply of respiratory and ophthalmic products. Its capabilities extend well beyond manufacturing, with an in-house development team specializing in all aspects of bringing a product to market - from lab scale batches, regulatory filings, scale-up, manufacturing and distribution.

    Initial challenges 
    The CDMO was looking to solve the issue of charging sterile drug substance into a mixing tank. This is a widespread problem in aseptic processing and particularly in formulation.
    It was vital that sterile conditions were maintained whilst docking a container to the vessel and then transferring solid drug substance to form a liquid suspension. With a fully dissolved liquid, the product could typically be sterile filtered as it was passed to the filler. Although in this case, the product being passed to the filler was a suspension and so this option was not possible.
    This required the process to be performed under aseptic conditions. As such, this would normally mean one of the following upgrades would be required:
    • Upgrade the entire room to a grade A cleanroom from a grade C;
    • Introduce an over-pressurized grade A area around the point of fill and upgrade the whole room to a grade B environment;
    • Implement a laminar flow system around the point of fill, plus additional control due to the lack of a barrier;
    • Introduce a RABS system at the point of fill or full vessel and upgrade the room to a grade B environment;
    • Maintain the grade C cleanroom but introduce isolator tech nology around the point of fill or full vessel.

    Generally, RABs and isolator technology would likely have been favored in this situation, due to the benefits both technologies can offer. This includes improved sterility assurance, employing the fundamental techniques of separation and decontamination. However, when considering some of the disadvantages associated with these technologies such as high initial investment, space, ergonomics and ongoing cost and energy consumption, the company decided to look for a solution that was more suited to the task.

    The solution
    The ChargePoint AseptiSafe Bio valve was selected as an ideal solution to this problem. The valve provided a sealed powder transfer mounted to the inlet port of the vessel. The valve could be pre-steam sterilized along with the vessel, unlike traditional SBVs or other conventional connections (see illustration 1a/b). On final connection, it also eliminated any room contamination from the mating faces of the transfer in a controlled and validated manner (see illustration 2a/b).

    The AseptiSafe Bio valve works by creating a sealed chamber between the passive section (transfer container) and the active section (vessel). The sealed chamber is bio decontaminated with vaporized hydrogen peroxide (VHP) when the two halves dock together.

    This removes any biological contamination to a validated 6-log reduction and leaves the space and mating faces clean and ready to dock together. Once mated, the disc can be opened. This allows the product to be securely transferred from transfer container to vessel, eliminating the risk of contamination. Performing this transfer within the grade C space provided considerable cost and production benefits.

    Process validation
    The first step in microbiologically validating the process was to generate a validated decontamination cycle for the VHP gassing stage. This consisted of four distinct phases, which the generator will run through to ensure a validated gassing cycle is performed each time.

    Dehumidification phase – The humidity is reduced within the chamber to provide ideal conditions for biological kill.

    Conditioning phase – VHP is introduced into the chamber to build up to levels to achieve good decontamination.

    Decontamination phase – VHP concentration is retained in order to deactivate any microbiological activity within the chamber.

    Aeration – On completion of the biological decontamination, the VHP is removed from the system so that no harmful levels of residue are left. In this instance, 0.4ppm was used as the acceptance level, as the client used a lower residue limit to ensure they had a robust system and no chance of contamination of their product due to gas residue.

    The full decontamination cycle can be accomplished in as little as four minutes although 20 minutes is more typical. For this application the process was only being performed once a day. To ensure a robust cycle was produced, additional time was added to each of the critical phases, ensuring that decontamination was confirmed, and gas was aerated from the system. This resulted in a 41-minute full cycle (see Table 1).

    Project learnings
    The installation is now in full production. The initial benefits predicted at the outset of the project, such as low capital equipment cost, smaller footprint and ease of installation, have been matched by improved sterility assurance, ease of use for operators, and low maintenance. The system is straightforward to use, easy to install and validate and has improved the CDMO’s process.

    One learning from this project was at the dispensing stage. At the time of validation, the system installed was a rigid reusable solution where pre-sterilized drug substance was supplied to the client in bags. These bags were opened and then subdivided and dispensed within an aseptic isolator to the pre-autoclaved transfer container and bio valve. It would have been beneficial to sterilize the product, container and transfer connection in one step through gamma irradiation, although this was not possible due to the constraints associated with gamma sterilizing stainless steel and elastomeric assemblies as one item.

    With the release of the ChargePoint disposable/single use range, the AseptiSafe Bio valve will be combined with single use passive and bag technology to allow this process to take place. This will allow the client to purchase the drug substance, bag (container) and passive in a pre-sterilized, gamma irradiated form which can be docked directly onto the active vessel and discharged.
    Alternatively, the client could purchase nonsterile drug substance, which is easier to handle. This can be dispensed into pre-sterilized single use bags with the integral passive half of the valve which can be docked and product transferred. The whole package could then be sent away for gamma sterilization, instead of having multiple individual sterilization and aseptic assembly steps, again making the process more streamlined, easier to handle and more cost effective.

    Final thought
    It will become increasingly important for containment technologies to be agile in order to adapt to evolving biomanufacturing requirements. This is an area in which SBVs can offer considerable benefits, due to their flexibility and ease of implementation. 

    Note: All illustrations and Table 1 are in the image slider at the top of the article.
    Suggested For You
    Biologics Development & Manufacturing Biologics Development & Manufacturing
    Chemical Development Chemical Development
    Precision Medicine Group Acquires Project Farma Precision Medicine Group Acquires Project Farma
    Charles River Partners with JADE Charles River Partners with JADE
    Cytiva Delivers Modular Biologics Factory to Lonza Cytiva Delivers Modular Biologics Factory to Lonza
    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    LSNE Expands Fill Finish and Lyophilization Ops LSNE Expands Fill Finish and Lyophilization Ops
    Pharmaceutical and Biotherapeutic Development and Testing Pharmaceutical and Biotherapeutic Development and Testing
    RheinCell Therapeutics Achieves GMP Certification RheinCell Therapeutics Achieves GMP Certification
    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Commercial Manufacturing Commercial Manufacturing
    Capricor, Lonza Enter CAP-1002 Development Agreement Capricor, Lonza Enter CAP-1002 Development Agreement
    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    Adagene Achieves CAR-T Collaboration Milestone  Adagene Achieves CAR-T Collaboration Milestone
    Drug Product Development, Manufacturing, and Packaging Drug Product Development, Manufacturing, and Packaging

    Related Features

    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20


    • Injectables
      Catering for the Complex

      Catering for the Complex

      The rapidly changing landscape of pharmaceutical packaging.
      Marcelo Cruz, Director Business Development and Marketing, Tjoapack 11.17.20

    • Cold Chain Management | Supply Chain
      Cold Chain Trends

      Cold Chain Trends

      There is a growing need for convenience through Direct-to-Patient and Direct-from-Patient services in clinical trials.
      Vince Paolizzi, Director of NanoCool Sales, Pelican BioThermal 11.17.20

    • Biologics, Proteins, Vaccines | Inspections | Supply Chain
      Inspecting the Unexpected

      Inspecting the Unexpected

      Preparing quality control processes for COVID-19 vaccine candidates.
      Dr. Andrea Sardella and Raffaele Pace, Stevanato Group 11.17.20


    • Scale-up/Technology Transfer
      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Ensuring Quality During the Transfer and Scale Up of Rx Drugs

      Defining the key parameters and considerations for a successful technology transfer.
      Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20

    • Scale-up/Technology Transfer
      Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up

      Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up

      Identifying, assessing and mitigating threats at every stage of the development pipeline.
      Joe Willmot, Application Leader, H.E.L Group 11.17.20

    • Clinical Trials | Information Technology
      The Role of Electronic Monitoring in Maintaining Medication Adherence

      The Role of Electronic Monitoring in Maintaining Medication Adherence

      Digital solutions offer hope to get patients to take their medications properly.
      Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20


    • APIs
      Understanding the Importance of Crystallization Processes

      Understanding the Importance of Crystallization Processes

      Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.
      Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20

    • Capsules | Solid Dosage/Creams/Ointments
      Capsule Technology Trends

      Capsule Technology Trends

      A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.
      Julien Lamps, Product Manager, Lonza 10.14.20

    • Aseptic Processing | Fill/Finish
      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

      Overcoming today’s aseptic fill-and-finish process challenges.
      Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20

    Trending
    • Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • Precision Medicine Group Acquires Project Farma
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Eriocitrin Shown to Have Metabolic Benefits in Recent Study
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login